Polypeptide hormone phosphatonin

Details Polypeptide hormone phosphatonin Polypeptide hormone phosphatonin

2006-08-29

2006-08-29

Andres, Janet L. (Department: 1649)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C435S069100, C530S350000

Reexamination Certificate

active

07098185

ABSTRACT:
The present invention relates to a novel human protein called phosphatonin, and isolated polynucleotides encoding this protein. Also provided are vectors, host cells, antibodies, and recombinant methods for producing this human protein. The invention further relates to diagnostic and therapeutic methods useful for diagnosing and treating disorders related to this novel human protein.

REFERENCES:
Slatopolsky et al., J. Amer. Soc. Nephol. 2003, vol. 14, suppl., s297-s299.
Aschinberg,J. Pediatr., 91 (1977) 55-60.
Carpenter,Pediatric Clinics of North America, 44 (1997) 443-466.
Drenzer,Primer on Metabolic Bone Diseases and Disorders of Mineral Metabolism(ed. Favus, M.J.) 184-188 (Am. Soc. Bone and Min. Res., Kelseyville, CA 1990).
Escarot,J. Bone Miner. Res., 7 (1992) 215-220.
Escarot, J.Bone Miner. Res., 10 (1995) 424-431.
Econs,Am. J. Physiol., 273 (1997) F489-F498.
Francis,Nat. Genet., 11 (1995), 130-136.
Francis,Baillieres Clinical Endrocrinology and Metabolism, 11 (1997) 145-163.
Glorieux,Arch Pediat., 4 (1997) 102s-105s.
Grieff,Current Opinion in Nephrology&Hypertension, 6 (1997) 15-19.
Hanna,Current Therapy in Endocrinology&Metabolism, 6 (1997) 533-540.
Henderson, J and Wang,D. Curr. Opin. Orthopaedics, 10 (1999) 3444-353.
Hilfiker,PNAS, 95(24) (1998) 14564-14569.
Iaokimidis,The J. Rheumatology, 21(6) (1994) 1162-1164.
Kumar,Nephrol. Dial. Transplant, 12 (1997) 11-13.
Lajeunesse,Kidney Int., 50 (1996) 1531-1538.
Lyles,Ann Intern. Med., 93 (1980) 275-278.
Meyer,J. Bone Miner. Res., 4 1989) 4933-500.
Meyer,J. Bone Miner. Res., 4(4) 1989) 523-532.
Miyauchi,J. Clin. Endocrinol. Matab., 67 (1988) 46-53.
Morgan,Arch, Intern. Med., 134 (1974) 549-552.
Nesbitt,J. Clin. Invest., 89 (1992) 1453-1459.
Nesbitt,J. Bone Miner. Res., 10 (1995) 1327-1333.
Nesbitt,Endocrinology, 137 (1996) 943-948.
Popovtzar,Clin. Res, 29 (1981), 418A (Abstract).
Qui,GEnet. Res. Camb., 62 (1993) 39-43.
Rowe,Hum. Genet., 94 (1994) 457-467.
Rowe,Bone, 18 (1996) 159-169.
Rowe,Hum. Genet., 97 (1996) 345-352.
Rowe,Hum. Mol. Genet., 6 (1997) 539-549.
Rowe,Exp. Nephrol., 5 (1997) 355-363.
Rowe,Current Opinion in Nephrology&Hypertension, 7(4) (1977) 367-376.
Shane,Journal of Bone and Mineral Research, 12 (1997) 1502-1511.
Weidner,Cancer, 59 (1987) 1442-1454.

Affiliated with

Also associated with

Rating

Polypeptide hormone phosphatonin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Polypeptide hormone phosphatonin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polypeptide hormone phosphatonin will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3709650